This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is supporting research to investigate the role of protein interactions in the formation of calcium oxalate kidney stones. The total award amount is $851,542 over the period from Aug 22, 2024 to Jun 30, 2028. The research aims to: 1) Test a range of protein/polymer compositions to understand how they...
This Cooperative Agreement award of $677,316, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports a collaborative research and training network in kidney, urologic, and hematologic (KUH) research across three major academic institutions in the San Diego region: UC San Diego, The Scripps Research Foundation, and San Diego State University. The network aims to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to leverage a unique dog model to investigate the role of the protein uromodulin in kidney stone disease. The $368,500 award, effective September 1, 2024 through August 31, 2025, will support research to identify how defects in uromodulin polymerization and peptide excretion impact renal...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), has awarded a $134,749 Project Grant to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The 5-year grant, effective September 1, 2024, supports the development of a novel nanotechnology-based treatment for kidney stones. The project aims to investigate how gold-based photothermal...
This $830,975 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) supports the Training Core for the San Diego Regional Network Award for Kidney, Urologic, and Hematologic Research Training. Over a 5-year period starting September 2024, this collaborative effort between UC San Diego, Scripps Research Institute, and San Diego State University will recruit and train 10 outstanding...
This Project Grant award of $2,727,306 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a Type I hybrid effectiveness-implementation study of the "Hypospadias Hub" - a parent-centered shared decision-making tool to improve decision quality for parents of children with hypospadias, a common birth defect affecting the penis. The primary objectives are to: 1) assess the...
This federal Cooperative Agreement award of $903,090.00 was granted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award will fund the Pittsburgh Center for Training in Kidney, Urology and Hematology (PCT-KUH) at the University of Pittsburgh to develop the next generation of KUH investigators. The program will provide predoctoral students, physicians, and PhDs with a...
The University of Pittsburgh was awarded a $1,690,337 Project Grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "Pittsburgh Center for Training in Kidney, Urology and Hematology (PCT-KUH)," is designed to prepare predoctoral students, MDs, and PhDs for biomedical research careers by providing concentrated, in-depth research experiences in...
This $1,543,110 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to New York University School of Medicine aims to better understand how the gut microbiome and other host factors determine urine oxalate levels. The research has three key objectives: Investigate the role of the "oxalobiome" (microbes that degrade oxalate) in determining urine oxalate excretion, and whether it differs between kidney stone formers and non-stone...
This $684,107 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under CFDA program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, supports research to determine the optimal settings for the Thulium Fiber Laser (TFL) in laser lithotripsy and assess associated thermal injury risk. The key objectives are to: 1) determine the optimal TFL settings through in-vitro studies, 2) elucidate the mechanisms of action of the...